These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 28927388)
1. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model. He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388 [TBL] [Abstract][Full Text] [Related]
2. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1. Zheng J; Xu T; Chen F; Zhang Y Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1. Mao M; Wu Z; Chen J Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872 [TBL] [Abstract][Full Text] [Related]
4. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation. Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of miR-139-5p in non-small cell lung cancer. Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351 [TBL] [Abstract][Full Text] [Related]
6. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
7. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1. Liang Z; Kong R; He Z; Lin LY; Qin SS; Chen CY; Xie ZQ; Yu F; Sun GQ; Li CG; Fu D; Jiang GX; Chen J; Ma YS Oncotarget; 2017 Jul; 8(29):47389-47399. PubMed ID: 28537888 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells. Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674 [TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
12. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features. Sun Y; Su B; Zhang P; Xie H; Zheng H; Xu Y; Du Q; Zeng H; Zhou X; Chen C; Gao W Oncol Rep; 2013 Feb; 29(2):704-12. PubMed ID: 23228962 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077 [TBL] [Abstract][Full Text] [Related]
16. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer. Zhuang ZL; Tian FM; Sun CL Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5132-5136. PubMed ID: 28051257 [TBL] [Abstract][Full Text] [Related]
18. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1. Xia LH; Yan QH; Sun QD; Gao YP Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2. Huang RS; Zheng YL; Li C; Ding C; Xu C; Zhao J Life Sci; 2018 Apr; 199():104-111. PubMed ID: 29510198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]